Education
About Us
Working with TipRanks
Follow Us
Artivion (AORT)
NYSE:AORT
Earnings Data
Report Date
Jul 31, 2025After Close (Confirmed)
Period Ending
2025 (Q2)Consensus EPS Forecast
>-0.01Last Year’s EPS
-0.05Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Artivion's earnings call highlighted strong revenue growth in key product lines and geographical regions, along with a successful launch of the AMDS product. However, challenges such as the impact of a cybersecurity incident and a decline in North American revenue were noted. Nevertheless, the overall outlook remains optimistic with raised revenue guidance and positive clinical data supporting future growth.Company Guidance -
Q2 2025
Total Revenue and Growth
Artivion reported total revenues of $99 million for the first quarter of 2025, up 4% compared to Q1 of 2024. The company raised its full-year 2025 revenue guidance, expecting constant currency growth of between 11% and 14%.
On-X and Stent Graft Revenue Growth
On-X revenue increased double digits at 11% year-over-year growth on a constant currency basis. Stent graft revenues grew 19% on a constant currency basis in the first quarter compared to the same period last year.
Successful AMDS Launch
Artivion's ongoing launch of AMDS in the U.S. following its FDA HDE approval has been positive. About 150 facilities are actively seeking IRB and value analysis committee approvals, indicating strong interest from the surgeon community.
Geographical Performance
Latin America and Asia Pacific delivered strong constant currency revenue growth of 26% and 8%, respectively, in the first quarter.
Positive Clinical Data for On-X
New data showed a statistically significant improvement in mortality with mechanical valves compared to bioprosthetic valves in patients under 60, opening a $100 million U.S. market expansion opportunity.
AORT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AORT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2025 | $23.77 | $27.42 | +15.36% |
Feb 24, 2025 | $27.85 | $25.56 | -8.22% |
Nov 07, 2024 | $28.98 | $28.71 | -0.93% |
Aug 08, 2024 | $25.33 | $24.85 | -1.89% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Artivion (AORT) report earnings?
Artivion (AORT) is schdueled to report earning on Jul 31, 2025, After Close (Confirmed).
What is Artivion (AORT) earnings time?
Artivion (AORT) earnings time is at Jul 31, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AORT EPS forecast?
AORT EPS forecast for the fiscal quarter 2025 (Q2) is >-0.01.